Franklin Resources’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21B | Buy |
|
|||||
|
2025
Q1 | $1.44B | Buy |
|
|||||
|
2024
Q4 | $1.46B | Buy |
|
|||||
|
2024
Q3 | $1.91B | Sell |
|
|||||
|
2024
Q2 | $2.02B | Buy |
|
|||||
|
2024
Q1 | $1.63B | Buy |
|
|||||
|
2023
Q4 | $425M | Buy |
|
|||||
|
2023
Q3 | $398M | Sell |
|
|||||
|
2023
Q2 | $351M | Sell |
|
|||||
|
2023
Q1 | $402M | Sell |
|
|||||
|
2022
Q4 | $363M | Sell |
|
|||||
|
2022
Q3 | $362M | Buy |
|
|||||
|
2022
Q2 | $310M | Sell |
|
|||||
|
2022
Q1 | $394M | Sell |
|
|||||
|
2021
Q4 | $399M | Buy |
|
|||||
|
2021
Q3 | $367M | Sell |
|
|||||
|
2021
Q2 | $342M | Buy |
|
|||||
|
2021
Q1 | $279M | Sell |
|
|||||
|
2020
Q4 | $298M | Sell |
|
|||||
|
2020
Q3 | $403M | Buy |
|
|||||
|
2020
Q2 | $442M | Buy |
|
|||||
|
2020
Q1 | $285M | Sell |
|
|||||
|
2019
Q4 | $248M | Sell |
|
|||||
|
2019
Q3 | $195M | Buy |
|
|||||
|
2019
Q2 | $213M | Buy |
|
|||||
|
2019
Q1 | $234M | Sell |
|
|||||
|
2018
Q4 | $217M | Sell |
|
|||||
|
2018
Q3 | $264M | Sell |
|
|||||
|
2018
Q2 | $238M | Sell |
|
|||||
|
2018
Q1 | $264M | Sell |
|
|||||
|
2017
Q4 | $308M | Buy |
|
|||||
|
2017
Q3 | $351M | Buy |
|
|||||
|
2017
Q2 | $381M | Sell |
|
|||||
|
2017
Q1 | $315M | Sell |
|
|||||
|
2016
Q4 | $335M | Buy |
|
|||||
|
2016
Q3 | $315M | Buy |
|
|||||
|
2016
Q2 | $266M | Buy |
|
|||||
|
2016
Q1 | $241M | Buy |
|
|||||
|
2015
Q4 | $346M | Buy |
|
|||||
|
2015
Q3 | $279M | Sell |
|
|||||
|
2015
Q2 | $310M | Buy |
|
|||||
|
2015
Q1 | $266M | Sell |
|
|||||
|
2014
Q4 | $248M | Buy |
|
|||||
|
2014
Q3 | $196M | Sell |
|
|||||
|
2014
Q2 | $240M | Sell |
|
|||||
|
2014
Q1 | $335M | Buy |
|
|||||
|
2013
Q4 | $142M | Buy |
|
|||||
|
2013
Q3 | $114M | Buy |
|
|||||
|
2013
Q2 | $38.8M | Buy |
|